Filana Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -33.8% | +23.5% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +16.1% | -33.4% | -62.6% | -22.7% | -2.6% | +17.9% | -27.3% | – | |
| – | -30.8% | +21.9% | +268.8% | -80.4% | +22.7% | -31.7% | -8.1% | – | |
| – | -3.7% | -16.6% | +84.6% | -73.9% | +11.2% | -17.1% | -16.8% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.